LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | 0.7 | - | 1.5 | 332.0 | 221.7 | 0.1 | - | - | 556.0 |
1 | - | - | - | - | - | 74.5 | 40.1 | - | - | - | 114.6 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | - |
1 | - |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | - |
1 | - |
Number of post synapses: 5560
Number of pre synapses: 1146
Number of output connections: 3907
Coverage factor: 1.7
Columnar completeness: 0.43
Area completeness: 0.59
Cell size (columns): 47
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#Cm22 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | MeTu3b (R) | ACh | 1,058 | 105.8 | 19.2% | 19.2% |
1 | MeVPMe10 (L) | Glu | 722 | 72.2 | 13.1% | 32.4% |
2 | Cm-DRA (R) | ACh | 627 | 62.7 | 11.4% | 43.8% |
3 | Dm-DRA1 (R) | Glu | 584 | 58.4 | 10.6% | 54.4% |
4 | MeTu3a (R) | ACh | 483 | 48.3 | 8.8% | 63.2% |
5 | Cm14 (R) | GABA | 361 | 36.1 | 6.6% | 69.7% |
6 | Mi15 (R) | ACh | 275 | 27.5 | 5.0% | 74.7% |
7 | Cm11d (R) | ACh | 236 | 23.6 | 4.3% | 79.0% |
8 | MeTu2a (R) | ACh | 160 | 16.0 | 2.9% | 81.9% |
9 | Cm31b (R) | GABA | 118 | 11.8 | 2.1% | 84.1% |
10 | Cm20 (R) | GABA | 101 | 10.1 | 1.8% | 85.9% |
11 | MeTu3c (R) | ACh | 96 | 9.6 | 1.7% | 87.6% |
12 | MeVP31 (R) | ACh | 93 | 9.3 | 1.7% | 89.3% |
13 | aMe17e (R) | Glu | 85 | 8.5 | 1.5% | 90.9% |
14 | aMe9 (R) | ACh | 61 | 6.1 | 1.1% | 92.0% |
15 | Tm39 (R) | ACh | 52 | 5.2 | 0.9% | 92.9% |
16 | aMe17a (R) | Glu | 48 | 4.8 | 0.9% | 93.8% |
17 | MeVC22 (R) | Glu | 39 | 3.9 | 0.7% | 94.5% |
18 | Cm18 (R) | Glu | 33 | 3.3 | 0.6% | 95.1% |
19 | Cm21 (R) | GABA | 27 | 2.7 | 0.5% | 95.6% |
20 | MeVC2 (L) | ACh | 21 | 2.1 | 0.4% | 96.0% |
21 | Mi10 (R) | ACh | 21 | 2.1 | 0.4% | 96.4% |
22 | Cm3 (R) | GABA | 17 | 1.7 | 0.3% | 96.7% |
23 | Cm4 (R) | Glu | 15 | 1.5 | 0.3% | 96.9% |
24 | MeTu2b (R) | unclear | 14 | 1.4 | 0.3% | 97.2% |
25 | aMe5 (R) | ACh | 12 | 1.2 | 0.2% | 97.4% |
26 | Dm2 (R) | ACh | 10 | 1.0 | 0.2% | 97.6% |
instance | NT | total connections | connections /#Cm22 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | MeTu2a (R) | ACh | 985 | 98.5 | 25.2% | 25.2% |
1 | Cm14 (R) | GABA | 390 | 39.0 | 10.0% | 35.2% |
2 | Cm4 (R) | Glu | 384 | 38.4 | 9.8% | 45.0% |
3 | Mi15 (R) | ACh | 362 | 36.2 | 9.3% | 54.3% |
4 | Cm35 (R) | GABA | 358 | 35.8 | 9.2% | 63.4% |
5 | MeTu2b (R) | unclear | 246 | 24.6 | 6.3% | 69.7% |
6 | Cm21 (R) | GABA | 239 | 23.9 | 6.1% | 75.8% |
7 | MeTu3a (R) | ACh | 133 | 13.3 | 3.4% | 79.2% |
8 | MeTu3c (R) | ACh | 126 | 12.6 | 3.2% | 82.5% |
9 | Dm-DRA1 (R) | Glu | 78 | 7.8 | 2.0% | 84.4% |
10 | MeTu3b (R) | ACh | 78 | 7.8 | 2.0% | 86.4% |
11 | MeVPMe3 (R) | Glu | 58 | 5.8 | 1.5% | 87.9% |
12 | aMe4 (R) | ACh | 51 | 5.1 | 1.3% | 89.2% |
13 | Cm-DRA (R) | ACh | 30 | 3.0 | 0.8% | 90.0% |
14 | MeVC22 (R) | Glu | 27 | 2.7 | 0.7% | 90.7% |
15 | aMe5 (R) | ACh | 26 | 2.6 | 0.7% | 91.4% |
16 | Cm30 (R) | GABA | 25 | 2.5 | 0.6% | 92.0% |
17 | Cm20 (R) | GABA | 18 | 1.8 | 0.5% | 92.5% |
18 | Cm32 (R) | GABA | 14 | 1.4 | 0.4% | 92.8% |
19 | Cm17 (R) | GABA | 13 | 1.3 | 0.3% | 93.1% |
20 | Cm18 (R) | Glu | 12 | 1.2 | 0.3% | 93.5% |
21 | Cm3 (R) | GABA | 12 | 1.2 | 0.3% | 93.8% |
22 | Cm5 (R) | GABA | 12 | 1.2 | 0.3% | 94.1% |
23 | MeVP15 (R) | ACh | 11 | 1.1 | 0.3% | 94.3% |
24 | TmY3 (R) | ACh | 10 | 1.0 | 0.3% | 94.6% |